Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
The right dose and schedule depend on age, weight, and how severe the deficiency is
compounded under Section 503A pharmacy rules Typical research dose / 250-500 mcg subcutaneous injection once daily Lethal dose in humans / none reported in published literature as of May 2026 GH-receptor activation / absent at standard and supra-pharmacologic doses per Heffernan et al
Of note, the relative abundance of the Parasutterella genus, which was significantly enriched in both the vehicle- and 5A-1MQ-treated animals transitioned from WD to LD compared to both the WD and LD control groups, was observed to be significantly correlated (either positively or negatively) with 30 EWAT metabolites, both with and without outliers included
Key Benefits
US$ 24.52
US$ 27.49
US$ 26.74
US$ 25.57
